A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
DIAGNOSTIC UTILITY OF PRESEPSIN AND PROCALCITONIN IN CRITICALLY ILL PATIENTS WITH SUSPECTED SEPSIS: COMPARISON WITH RECENT CLINICAL CRITERIA OF SEPSIS-3
2019
International Journal of Medical and Biomedical Studies
In this study, we aimed to investigate the diagnostic and prognostic utilities of presepsin and procalcitonin (PCT) in critically ill patients with suspected sepsis, for whom sepsis was diagnosed clinically based on the Survival Sepsis Campaign (SSC) criteria and to compare it with recent criteria of Sepsis-3. Methods: Blood samples for biomarker measurements of presepsin and PCT were drawn on days 1, 3 and 7 of ICU admission in a total of 26 patients. All patients were followed-up until death
doi:10.32553/ijmbs.v3i6.309
fatcat:fhgevg7f7rg5zixl6efgxwlq24